MedTrace Logo

Enhanced Recovery After Surgery (ERAS) in Patients Undergoing Gynecologic Surgery

NCT07764276 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-08-13

No results posted yet for this study

Summary

Enhanced Recovery After Surgery (ERAS) is a multidisciplinary perioperative care program designed to reduce surgical stress, accelerate postoperative recovery, and improve clinical outcomes. This prospective, non-randomized study aims to evaluate the effectiveness of an ERAS program in patients undergoing gynecologic surgery at National Taiwan University Hospital Hsin-Chu Branch. Patients who choose to participate in the ERAS program will receive perioperative care according to the institutional ERAS protocol, while those who choose conventional perioperative care will serve as the comparison group. Perioperative outcomes, postoperative recovery, postoperative complications, pain scores, and other clinical outcomes will be compared between the two groups to evaluate the clinical impact of implementing an ERAS program.

Conditions

  • ERAS
  • Gynecologic Surgery
  • Gynecologic Oncological Pelvic/Abdominal Surgery

Interventions

OTHER

Enhanced Recovery After Surgery (ERAS)

A multidisciplinary perioperative care program designed to reduce surgical stress and enhance postoperative recovery.

OTHER

Conventional Perioperative Care

Standard perioperative care according to routine institutional practice.

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chia-Yi Lee, MD · National Taiwan University Hospital Hsin-Chu Branch

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-16
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07764276 on ClinicalTrials.gov